Sign in to view content

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results

Jeffrey S. Heier, MD

Video
Published 2019

Jeffrey S. Heier, MD

AMD Non-neovascular Symposium

Related

Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Instrumentation & Devices Symposium 2
Annual Meeting Talks
2020

Category: AMD-Non-Neovascular

See more